🔎 Trials Near Me

홈 › 급성 이표형 백혈병 › 노스캐롤라이나

노스캐롤라이나의 급성 이표형 백혈병 임상 시험

급성 이표형 백혈병 관련 연구 11개가 노스캐롤라이나 내 여러 지역에서 참여자를 모집하고 있습니다.

노스캐롤라이나의 도시

공식 연구 텍스트(영어)

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
피험자 모집 중관찰 연구
18세 ~ 120세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT01137643

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • Duke University Medical Center, Durham
  • 외 2개
피험자 모집 중2상
365 Days · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06317662

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill
피험자 모집 중1/2상
13세 ~ 90세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06533579

A Study of Revumenib and Mezigdomide in People With Leukemia

  • University of North Carolina (Data Collection Only), Chapel Hill
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT07356154

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  • Duke University Medical Center, Durham
피험자 모집 중1/2상
30 Days · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT04065399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Mission Hospital, Asheville
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • 외 4개
피험자 모집 중3상
365 Days – 25 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Mission Hospital, Asheville
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • 외 4개
피험자 모집 중1/2상
22세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04726241

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

  • Novant Health Presbyterian Hemby Children's Hospital, Charlotte
피험자 모집 중2상
1세 ~ 18세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06390319

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

  • Novant Health Presbyterian Hemby Children's Hospital, Charlotte
피험자 모집 중4상
1세 ~ 18세 · 모든 성별 · 2026. 7. 14. 업데이트됨 · NCT06289673

Registry of Older Patients With Cancer

  • Seby B. Jones Cancer Center, Boone
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
  • East Carolina University, Greenville
  • 외 4개
피험자 모집 중관찰 연구
65세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT01137825

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Carolina-Levine Children's Hospital, Charlotte
피험자 모집 중1상
1세 ~ 21세 · 모든 성별 · 2024. 12. 6. 업데이트됨 · NCT05476770

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.